Skip to main navigation Skip to search Skip to main content

Atypical Presentation of Erythema Nodosum Following Pfizer-BioNTech COVID-19 Vaccine

  • Nasser Alzoabi
  • , Jamal Alqahtani
  • , Bader Algamdi
  • , Mohammed Almutairi*
  • , Jumana Alratroot
  • , Saud Alkhaldi
  • , Shatha Alqahtani
  • , Omar Alakloby
  • *Corresponding author for this work
  • Imam Abdulrahman Bin Faisal University
  • King Faisal University
  • Najran University

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Erythema nodosum (EN) is a common form of panniculitis that could be trig-gered by numerous conditions including infectious and non-infectious conditions. So far, few cases of EN caused by COVID-19 vaccine had been reported. Case Report: We report a case of atypical presentation of EN mimicking cellulitis in a patient who received the first dose of the Pfizer-BioNTech COVID-19 vaccine. A 38-year-old healthy woman who developed painful swelling on the left leg one week after receiving the first dose of Pfizer-BioN-Tech COVID-19 vaccine. Skin biopsy was revealed septal panniculitis. Due to the tempo-ral association and the absence of other identifiable causes, Pfizer-BioNTech COVID-19 vaccine-related EN would be the most likely explanation. Conclusion: COVID-19 vaccines could be associated with rare side effects that should be reported for a better understand-ing of related outcomes of COVID-19 vaccination. This case was reported to keep in mind that EN can have atypical presentation as a rare side effect of COVID-19 vaccines.

Original languageEnglish
Pages (from-to)72-74
Number of pages3
JournalMedical Archives
Volume76
Issue number1
DOIs
StatePublished - 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • COVID-19
  • COVID-19 vaccine
  • Erythema Nodosum

Fingerprint

Dive into the research topics of 'Atypical Presentation of Erythema Nodosum Following Pfizer-BioNTech COVID-19 Vaccine'. Together they form a unique fingerprint.

Cite this